Cardiovascular Diabetology,
Journal Year:
2021,
Volume and Issue:
20(1)
Published: Feb. 27, 2021
Abstract
The
epidemic
of
diabetes
mellitus
(DM)
necessitates
the
development
novel
therapeutic
and
preventative
strategies
to
attenuate
complications
this
debilitating
disease.
Diabetic
cardiomyopathy
(DCM)
is
a
frequent
disorder
affecting
individuals
diagnosed
with
DM
characterized
by
left
ventricular
hypertrophy,
diastolic
systolic
dysfunction
myocardial
fibrosis
in
absence
other
heart
diseases.
Progression
DCM
associated
impaired
cardiac
insulin
metabolic
signaling,
increased
oxidative
stress,
mitochondrial
cardiomyocyte
calcium
metabolism,
inflammation.
Various
non-coding
RNAs,
such
as
microRNAs
(miRNAs)
long
RNAs
(lncRNAs),
well
their
target
genes
are
implicated
complex
pathophysiology
DCM.
It
has
been
demonstrated
that
miRNAs
lncRNAs
play
an
important
role
maintaining
homeostasis
through
regulation
multiple
genes,
thus
they
attract
substantial
scientific
interest
biomarkers
for
diagnosis,
prognosis
potential
strategy
complications.
This
article
will
review
different
lncRNA
studied
context
DM,
including
type
1
2
contribution
pathophysiological
mechanisms
inflammatory
response,
apoptosis,
hypertrophy
.
Acta Pharmaceutica Sinica B,
Journal Year:
2021,
Volume and Issue:
12(2), P. 708 - 722
Published: Oct. 19, 2021
Herein,
we
define
the
role
of
ferroptosis
in
pathogenesis
diabetic
cardiomyopathy
(DCM)
by
examining
expression
key
regulators
mice
with
DCM
and
a
new
ex
vivo
model.
Advanced
glycation
end-products
(AGEs),
an
important
pathogenic
factor
DCM,
were
found
to
induce
engineered
cardiac
tissues
(ECTs),
as
reflected
through
increased
levels
Ptgs2
lipid
peroxides
decreased
ferritin
SLC7A11
levels.
Typical
morphological
changes
cardiomyocytes
observed
using
transmission
electron
microscopy.
Inhibition
ferrostatin-1
deferoxamine
prevented
AGE-induced
ECT
remodeling
dysfunction.
Ferroptosis
was
also
evidenced
heart
type
2
DCM.
liproxstatin-1
development
diastolic
dysfunction
at
3
months
after
onset
diabetes.
Nuclear
erythroid
2-related
(NRF2)
activated
sulforaphane
inhibited
cell
both
AGE-treated
ECTs
hearts
upregulating
The
protective
effect
on
AMP-activated
protein
kinase
(AMPK)-dependent.
These
findings
suggest
that
plays
essential
DCM;
prevents
associated
via
AMPK-mediated
NRF2
activation.
This
suggests
feasible
therapeutic
approach
clinically
prevent
Circulation,
Journal Year:
2022,
Volume and Issue:
146(20), P. 1537 - 1557
Published: Oct. 19, 2022
Exercise
is
an
effective
nonpharmacological
strategy
to
alleviate
diabetic
cardiomyopathy
(DCM)
through
poorly
defined
mechanisms.
FGF21
(fibroblast
growth
factor
21),
a
peptide
hormone
with
pleiotropic
benefits
on
cardiometabolic
homeostasis,
has
been
identified
as
exercise
responsive
factor.
This
study
aims
investigate
whether
signaling
mediates
the
of
DCM,
and
if
so,
elucidate
underlying
The
global
or
hepatocyte-specific
knockout
mice,
cardiomyocyte-selective
β-klotho
(the
obligatory
co-receptor
for
FGF21)
their
wild-type
littermates
were
subjected
high-fat
diet
feeding
injection
streptozotocin
induce
followed
by
6-week
intervention
assessment
cardiac
functions.
Cardiac
mitochondrial
structure
function
assessed
electron
microscopy,
enzymatic
assays,
measurements
fatty
acid
oxidation
ATP
production.
Human
induced
pluripotent
stem
cell-derived
cardiomyocytes
used
receptor
postreceptor
pathways
conferring
protective
effects
against
toxic
lipids-induced
dysfunction.
Treadmill
markedly
expression
significantly
attenuated
diabetes-induced
dysfunction
in
accompanied
reduced
damage
increased
activities
enzymes
hearts.
However,
such
cardioprotective
largely
abrogated
mice
hepatocyte-selective
ablation
FGF21,
cardiomyocyte-specific
deletion
β-klotho.
Mechanistically,
enhanced
actions
deacetylase
SIRT3
AMPK-evoked
phosphorylation
FOXO3,
thereby
reversing
hyperacetylation
functional
impairments
cluster
enzymes.
prevented
oxidative
stress
induction
AMPK/FOXO3/SIRT3
axis
human
cardiomyocytes.
Adeno-associated
virus-mediated
restoration
was
sufficient
restore
responsiveness
amelioration
DCM.
FGF21-SIRT3
DCM
preserving
integrity
represents
potential
therapeutic
target
URL:
https://www.
gov;
Unique
identifier:
NCT03240978.
Frontiers in Medicine,
Journal Year:
2021,
Volume and Issue:
8
Published: June 30, 2021
Individuals
with
diabetes
mellitus
(DM)
disclose
a
higher
incidence
and
poorer
prognosis
of
heart
failure
(HF)
than
non-diabetic
people,
even
in
the
absence
other
HF
risk
factors.
The
adverse
impact
on
likely
reflects
an
underlying
"diabetic
cardiomyopathy"
(DM-CMP),
which
may
by
exacerbated
left
ventricular
hypertrophy
coronary
artery
disease
(CAD).
pathogenesis
DM-CMP
has
been
hot
topic
research
since
its
first
description
is
still
under
active
investigation,
as
complex
interplay
among
multiple
mechanisms
play
role
at
systemic,
myocardial,
cellular/molecular
levels.
Among
these,
metabolic
abnormalities
such
lipotoxicity
glucotoxicity,
mitochondrial
damage
dysfunction,
oxidative
stress,
abnormal
calcium
signaling,
inflammation,
epigenetic
factors,
others.
These
disturbances
predispose
diabetic
to
extracellular
remodeling
hypertrophy,
thus
leading
diastolic
systolic
dysfunction.
This
Review
aims
outline
major
pathophysiological
changes
myocardial
cardiac
functional
derangement
DM-CMP.
Oxidative Medicine and Cellular Longevity,
Journal Year:
2022,
Volume and Issue:
2022, P. 1 - 12
Published: Dec. 31, 2022
Background.
Diabetes
mellitus
(DM)
can
induce
cardiomyocyte
injury
and
lead
to
diabetic
cardiomyopathy
(DCM)
which
presently
has
no
specific
treatments
consequently
increase
risk
of
mortality.
Objective.
To
characterize
the
therapeutic
effect
6-gingerol
(6-G)
on
DCM
identify
its
potential
mechanism.
Methods.
In
vivo
streptozotocin-
(STZ-)
induced
DM
model
was
established
by
using
a
high-fat
diet
STZ,
followed
low-dose
(25
mg/kg)
high-dose
(75
6-G
intervention.
For
an
in
vitro
model,
H9c2
rat
cardiomyoblast
cells
were
stimulated
with
high
glucose
(
glucose=33
mM)
palmitic
acid
(100
μM)
then
treated
μM).
Histological
echocardiographic
analyses
used
assess
cardiac
structure
function
DCM.
Western
blotting,
ELISA,
real-time
qPCR
expression
ferroptosis,
inflammation,
Nrf2/HO-1
pathway-related
proteins
RNAs.
Protein
collagen
I
III
assessed
immunohistochemistry,
kits
assay
SOD,
MDA,
iron
levels.
Results.
The
results
showed
that
decreased
both
mouse
cell
models
hypertrophy
interstitial
fibrosis
attenuated
treatment
resulted
improved
heart
function.
inhibited
ferroptosis-related
protein
FACL4
content
enhanced
anti-ferroptosis-related
GPX4.
addition,
also
diminished
secretion
inflammatory
cytokines,
including
IL-1β,
IL-6,
TNF-α.
activated
pathway,
antioxidative
stress
capacity
proved
increased
activity
MDA
production.
Compared
vivo,
could
produce
similar
effect.
Conclusion.
These
findings
suggest
protect
against
mechanism
ferroptosis
inhibition
inflammation
reduction
via
enhancing
pathway.
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: June 15, 2022
Diabetes
is
a
chronic
metabolic
disease
that
increasing
in
prevalence
and
causes
many
complications.
Diabetic
cardiomyopathy
(DCM)
complication
of
diabetes
associated
with
high
mortality,
but
it
not
well
defined.
Nevertheless,
generally
accepted
DCM
refers
to
clinical
occurs
patients
involves
ventricular
dysfunction,
the
absence
other
cardiovascular
diseases,
such
as
coronary
atherosclerotic
heart
disease,
hypertension,
or
valvular
disease.
However,
currently
uncertain
whether
pathogenesis
directly
attributable
dysfunction
secondary
diabetic
microangiopathy.
Oxidative
stress
(OS)
considered
be
key
component
its
pathogenesis.
The
production
reactive
oxygen
species
(ROS)
cardiomyocytes
vicious
circle,
resulting
further
ROS,
mitochondrial
DNA
damage,
lipid
peroxidation,
post-translational
modification
proteins,
inflammation,
cardiac
hypertrophy
fibrosis,
ultimately
leading
cell
death
dysfunction.
ROS
have
been
shown
affect
various
signaling
pathways
involved
development
DCM.
For
instance,
OS
disorders
by
affecting
regulation
PPARα,
AMPK/mTOR,
SIRT3/FOXO3a.
Furthermore,
participates
inflammation
mediated
NF-κB
pathway,
NLRP3
inflammasome,
TLR4
pathway.
also
promotes
TGF-β-,
Rho-ROCK-,
Notch-mediated
remodeling,
calcium
homeostasis,
which
impairs
ATP
overproduction.
In
this
review,
we
summarize
link
DCM,
intention
identifying
appropriate
targets
new
antioxidant
therapies
for
Aging and Disease,
Journal Year:
2022,
Volume and Issue:
13(6), P. 1787 - 1787
Published: Jan. 1, 2022
As
an
important
NAD+-dependent
enzyme,
SIRT6
has
received
significant
attention
since
its
discovery.
In
view
of
observations
that
SIRT6-deficient
animals
exhibit
genomic
instability
and
metabolic
disorders
undergo
early
death,
long
been
considered
a
protein
longevity.
Recently,
growing
evidence
demonstrated
functions
as
deacetylase,
mono-ADP-ribosyltransferase
fatty
deacylase
participates
in
variety
cellular
signaling
pathways
from
DNA
damage
repair
the
stage
to
disease
progression.
this
review,
we
elaborate
on
specific
substrates
molecular
mechanisms
various
physiological
pathological
processes
detail,
emphasizing
links
aging
(genomic
damage,
telomere
integrity,
repair),
metabolism
(glycolysis,
gluconeogenesis,
insulin
secretion
lipid
synthesis,
lipolysis,
thermogenesis),
inflammation
cardiovascular
diseases
(atherosclerosis,
cardiac
hypertrophy,
heart
failure,
ischemia-reperfusion
injury).
addition,
most
recent
advances
regarding
modulators
(agonists
inhibitors)
potential
therapeutic
agents
for
SIRT6-mediated
are
reviewed.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 8, 2023
Abstract
In
this
study,
we
identified
that
a
conserved
circular
RNA
(circRNA)
DICAR,
which
was
downregulated
in
diabetic
mouse
hearts.
DICAR
had
an
inhibitory
effect
on
cardiomyopathy
(DCM),
as
the
spontaneous
cardiac
dysfunction,
cell
hypertrophy,
and
fibrosis
occurred
deficiency
(
+/−
)
mice,
whereas
DCM
alleviated
DICAR-overexpressed
Tg
mice.
At
cellular
level,
found
overexpression
of
inhibited,
but
knockdown
enhanced
cardiomyocyte
pyroptosis.
molecular
DICAR-VCP-Med12
degradation
could
be
underlying
mechanism
DICAR-mediated
effects.
The
synthesized
junction
part
(DICAR-JP)
exhibited
similar
to
entire
DICAR.
addition,
expression
circulating
blood
cells
plasma
from
patients
lower
than
health
controls,
consistent
with
decreased
DICAR-JP
may
drug
candidates
for
DCM.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(1), P. 858 - 858
Published: Jan. 3, 2023
Diabetic
cardiomyopathy
(DCM)
is
a
myocardial
disease
independent
of
other
cardiovascular
diseases,
such
as
coronary
heart
disease,
hypertension,
etc.
Lipotoxicity
closely
related
to
DCM.
In
this
study,
we
investigated
the
mechanism
lipid
metabolism
disturbance
in
DCM
HL-1
cells.
Through
bioinformatics
and
Western
blotting
analysis,
found
that
canagliflozin
(CAN)
significantly
inhibited
expression
inflammatory
factors
cyclooxygenase-2
(COX-2)
inducible
nitric
oxide
synthase
(iNOS).
Ferroptosis
mediated
by
peroxidation.
We
demonstrated
presence
ferroptosis
cardiomyocytes
detecting
intracellular
Fe2+
content
levels
reactive
oxygen
species
(ROS),
malondialdehyde
(MDA),
reduced
glutathione
(GSH),
mitochondrial
membrane
potential
(MMP).
CAN
could
regulate
indicators
ferroptosis.
By
using
specific
inhibitors
celecoxib
(coxib),
S-methylisothiourea
sulfate
(SMT),
Ferrostatin-1
(Fer-1),
Compound
C,
further
regulated
inflammation
through
AMP-activated
protein
(AMPK),
interacted
with
Our
study
indicated
attenuated
lipotoxicity
regulating
activating
AMPK
pathway.
This
provides
new
direction
some
information
for
treatment
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: May 31, 2024
Abstract
The
immune
response
holds
a
pivotal
role
in
cardiovascular
disease
development.
As
multifunctional
cells
of
the
innate
system,
macrophages
play
an
essential
initial
inflammatory
that
occurs
following
injury,
thereby
inducing
subsequent
damage
while
also
facilitating
recovery.
Meanwhile,
diverse
phenotypes
and
phenotypic
alterations
strongly
associate
with
distinct
types
severity
diseases,
including
coronary
heart
disease,
valvular
myocarditis,
cardiomyopathy,
failure,
atherosclerosis
aneurysm,
which
underscores
importance
investigating
macrophage
regulatory
mechanisms
within
context
specific
diseases.
Besides,
recent
strides
single-cell
sequencing
technologies
have
revealed
heterogeneity,
cell–cell
interactions,
downstream
therapeutic
targets
at
higher
resolution,
brings
new
perspectives
into
macrophage-mediated
potential
Remarkably,
myocardial
fibrosis,
prevalent
characteristic
most
cardiac
remains
formidable
clinical
challenge,
necessitating
profound
investigation
impact
on
fibrosis
In
this
review,
we
systematically
summarize
functional
plasticity
diseases
unprecedented
insights
introduced
by
technologies,
focus
different
causes
characteristics
especially
relationship
between
inflammation
(myocardial
infarction,
pressure
overload,
dilated
diabetic
cardiomyopathy
aging)
vascular
injury
(atherosclerosis
aneurysm).
Finally,
highlight
preclinical/clinical
targeting
strategies
translational
implications.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(1), P. 123 - 123
Published: Jan. 4, 2023
The
global
prevalence
of
diabetes
continues
to
increase
partly
due
rapid
urbanization
and
an
in
the
aging
population.
Consequently,
this
is
associated
with
a
parallel
diabetic
vascular
complications
which
significantly
worsen
burden
diabetes.
For
these
complications,
there
still
unmet
need
for
safe
effective
alternative/adjuvant
therapeutic
interventions.
There
also
increasing
urge
options
come
from
natural
products
such
as
plants.
Hyperglycemia-induced
oxidative
stress
central
development
complications.
Furthermore,
stress-induced
inflammation
insulin
resistance
are
endothelial
damage
progression
Human
animal
studies
have
shown
that
polyphenols
could
reduce
stress,
hyperglycemia,
prevent
including
retinopathy,
nephropathy,
peripheral
neuropathy.
Part
effects
attributed
their
modulatory
effect
on
endogenous
antioxidant
systems.
This
review
attempts
summarize
established
systems
literature.
Moreover,
potential
strategies
harnessing
benefits
discussed.